Impact of Antimicrobial Agents and Chemotherapy from 1972 to 1998

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 8, 2000, Pages 2009-2016

  Swartz, Morton N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTHELMINTIC AGENT; ANTIFILARIAL AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTILEISHMANIAL AGENT; ANTIMALARIAL AGENT; ANTIMYCOBACTERIAL AGENT; ANTIPARASITIC AGENT; ANTITRYPANOSOMAL AGENT; ANTIVIRUS AGENT; BACITRACIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLORTETRACYCLINE; DACTINOMYCIN; EFLORNITHINE; ERYTHROMYCIN; GRISEOFULVIN; NIFURTIMOX; NOVOBIOCIN; NYSTATIN; OLEANDOMYCIN; OXYTETRACYCLINE; PENICILLIN G; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STREPTOMYCIN; UNINDEXED DRUG; VALACICLOVIR; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BLEEDING TENDENCY; FOOD AND DRUG ADMINISTRATION; GRAM NEGATIVE INFECTION; HUMAN; LIVER TOXICITY; MYCOSIS; NEPHROTOXICITY; PARASITISM; PRIORITY JOURNAL; SHORT SURVEY; VIRUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CLINICAL TRIALS; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; VIRUS DISEASES;

EID: 0033915368     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.8.2009-2016.2000     Document Type: Short Survey

References (21)

1. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
2. Friedland, I. R., M. Paris, S. Ehrett, S. Hickey, K. Olsen, and G. H. McCracken. 1993. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 37:1630-1636.
3. Gilbert, D. N. 1991. Once-daily aminoglycoside therapy. Antimicrob. Agents Chemother. 35:399-405.
4. Gootz, T. D., and C. C. Sanders. 1993. Characterization of β-lactamase induction in Enterobacter cloacae. Antimicrob. Agents Chemother. 23:91-97.
5. Hakenbeck, R., M. Tarpay, and A. Tomasz. 1980. Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17:364-371.
6. Herman, D. J., and D. Gerding. 1991. Antimicrobial resistance among enterococci. Antimicrob. Agents Chemother. 35:1-4.
7. Hershberger, E., J. R. Aeschlimann, T. Moldovan, and M. J. Rybak. 1999. Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods. Antimicrob. Agents Chemother. 43:717-721.
8. Ho, P. L., T. L. Que, D. N. Tsang, et al. 1999. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 43:1310-1313.
9. Hook, E. W., III, R. B. Roberts, and M. E. Sande. 1975. Antimicrobial therapy of experimental endocarditis. Antimicrob. Agents Chemother. 8: 564-570.
10. Horodniceanu, T., L. Bougueleret, N. El-Solh, G. Bieth, and F. Delbos. 1979. High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob. Agents Chemother. 16:686-689.
11. Jacoby, G. A. 1999. History of Antimicrobial Agents and Chemotherapy from 1972 to 1998. Antimicrob. Agents Chemother. 43:999-1002.
12. Johnson, W. D., Jr., E. W. Hook, E. Lindsey, and D. Kaye. 1973. Treatment of chronic typhoid carriers with ampicillin. Antimicrob. Agents Chemother. 3:439-440.
13. Paris, M. M., O. Ramilo, and G. H. McCracken, Jr. 1995. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:2171-2175.
14. Philippon, A., R. Labia, and G. Jacoby. 1989. Extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 33:1131-1136.
15. Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41:223-232.
16. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawada, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP105 and DuP721. Antimicrob. Agents Chemother. 31:1791-1797.
17. Swaney, S. M., H. Aoki, M. G. Ganoza, and D. L. Shinabarger. 1998. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob. Agents Chemother. 42:3251-3255.
18. Tally, F. P., G. J. Cuchural, N. V. Jacobus, S. L. Gorbach, K. E. Aldridge, T. J. Cleary, S. M. Finegold, G. B. Hill, P. B. Tannini, R. V. McCloskey, and C. L. Pierson. 1983. Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob. Agents Chemother. 23:536-540.
19. Vu, H., and H. Nikaido. 1985. Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase constitutive Enterobacter cloacae strain to expanded spectrum beta-lactams. Antimicrob. Agents Chemother. 27:393-398.
20. Waksman, S. A. 1960. Antibiotics today: a survey of accomplishments, problems, and potentialities, p. xvi-xviii. In Antimicrobial agents annual 1960. American Society for Industrial Microbiology.
21. Zighelboim, S., and A. Tomasz. 1980. Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17:434-442.